Peran Bifidobakteria dalam Pencegahan dan Pengobatan Alergi serta Gangguan Sistem Imun pada Anak

Ketut Dewi Kumara Wati, Budi Setiabudiawan

Sari


Bifidobakteria berperan dalam dinamika maturasi sistem imun dan memiliki timeline yang terhubung dengan timelinesistem imun. Bifidobakteria membantu pembentukan sistem imun nonspesifik maupun spesifik sedangkan sistem imun membantu pembentukan komposisi bifidobakteria. Bifidobakteria dapat berperan dalam sistem imun karena memiliki banyak enzim yang menunjang kolonisasi, mampu memelihara homeostasis mukosa intestinal, bekerjasama dengan mukus dan SIgA memerangkap patogen, membantu pembentukan SIgA dan IgM, serta meningkatkan survival koloni Treg. Secara klinis, penggunaan bifidobakterium tunggal maupun kombinasi bermanfaat untuk pencegahan dan pengobatan kasus alergi dan gangguan sistem imun. Pemberian bifidobakteria pada dosis 109 colony forming unit satu hingga dua bulan sebelum kelahiran dilanjutkan pemberian pada bayi selama 6 bulan menurunkan kejadian dermatitis atopik. Pemberian bifidobakteria pada bayi prematur memperbaiki profil kolonisasi bifidobakteria, menurunkan kejadian,dan keparahan nerotizing enterocolitis. Pemberian bifidobakteria memperbaiki kualitas hidup rinitis alergi musiman dan asma intermiten, menurunkan skor dermatitis (SCORAD) dan penggunaan steroid pada dermatitis atopik, serta membantu menurunkan berulangnya infeksi saluran nafas pada anak. 


Kata Kunci


bifidobakteria; sistem imun; maturasi; alergi; necrotizing enterocolitis; infeksi

Teks Lengkap:

PDF

Referensi


Kalliomäki M, Kirjavainen P, Eerola E, Kero P, Salminen S, Isolauri E. Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing. J Allergy Clin Immunol 2001;107:129–34.

He F, Ouwehand AC, Isolauri E, Hashimoto H, Benno Y, Salminen S. Comparison of mucosal adhesion and species identification of bifidobacterium from healthy and allergic infants. FEMS Immunol Med Microbiol. 2001;30(1):43-47.

Nuriel-Ohayon M, Neuman H, Ziv O, dkk. Progesterone Increases Bifidobacterium Relative Abundance during Late Pregnancy. Cell Rep 2019;27:730-736.e3.

Underwood MA, German JB, Lebrilla CB, Mills DA. Bifidobacterium longum subspecies infantis: Champion colonizer of the infant gut. Pediatr Res. 2015;77:229–35.

Collado MC, Rautava S, Aakko J, Isolauri E, Salminen S. Human gut colonisation may be initiated in utero by distinct microbial communities in the placenta and amniotic fluid. Sci Rep 2016;6:1–13.

Wopereis H, Oozeer R, Knipping K, Belzer C, Knol J. The first thousand days - intestinal microbiology of early life: Establishing a symbiosis. Pediatr Allergy Immunol 2014;25:428–38.

O’Sullivan A, Farver M, Smilowitz JT. The Influence of early infant-feeding practices on the intestinal microbiome and body composition in infants. Nutr Metab Insights 2015;8:18–20.

O’Callaghan A, van Sinderen D. Bifidobacteria and their role as members of the human gut microbiota. Front Microbiol 2016;7:925.

Ruiz L, Gueimonde M, Couté Y, dkk. Evaluation of the ability of Bifidobacterium longum to metabolize human intestinal mucus. FEMS Microbiol Lett 2011;314:125–30.

Martin R, Nauta AJ, Ben Amor K, Knippels LMJ, Knol J, Garssen J. Early life: Gut microbiota and immune development in infancy. Benef Microbes 2010;1:367–82.

Simon AK, Hollander GA, McMichael A. Evolution of the immune system in humans from infancy to old age. Proc R Soc B Biol Sci 2015;282:20143085.

Kisiela M, Skarka A, Ebert B, Maser E. Hydroxysteroid dehydrogenases in bacteria - A bioinformatic perspective. J Steroid Biochem Mol Biol 2012;129:31–46.

Kaoutari A El, Armougom F, Gordon JI, Raoult D, Henrissat B. The abundance and variety of carbohydrate-active enzymes in the human gut microbiota. Nat Rev Microbiol 2013;11:497–504.

Ballard O, Morrow AL. Human Milk Composition. Nutrients and Bioactive Factors. Pediatr Clin North Am 2013;60:49–74.

Zivkovic AM, German JB, Lebrilla CB, Mills DA. Human milk glycobiome and its impact on the infant gastrointestinal microbiota. Proc Natl Acad Sci U S A 2011;108:4653–8.

Rogier EW, Frantz AL, Bruno MEC, Kaetzel CS. Secretory IgA is concentrated in the outer layer of colonic mucus along with gut bacteria. Pathogens 2014;3:390–403.

Rogier EW, Frantz AL, Bruno MEC, dkk. Lessons from mother: Long-term impact of antibodies in breast milk on the gut microbiota and intestinal immune system of breastfed offspring. Gut Microbes 2015;5:663–8.

Mantis NJ, Forbes SJ. Secretory IgA: Arresting microbial pathogens at epithelial borders. Immunol Invest 2010;39:383–406.

Johansson MEV, Holmén Larsson JM, Hansson GC. The two mucus layers of colon are organized by the MUC2 mucin, whereas the outer layer is a legislator of host-microbial interactions. Proc Natl Acad Sci U S A 2011;108:4659–65.

Ruiz L, Delgado S, Ruas-Madiedo P, Sánchez B, Margolles A. Bifidobacteria and their molecular communication with the immune system. Front Microbiol 2017;8:1–9.

Owen JL, Mohamadzadeh M. Microbial activation of gut dendritic cells and the control of mucosal immunity. J Interf Cytokine Res 2013;33:619–31.

Suzuki K, Kawamoto S, Maruya M, Fagarasan S. GALT. Organization and dynamics leading to IgA synthesis. Adv Immunol 2010;107:153–185.

Kaetzel CS. Cooperativity among secretory IgA, the polymeric immunoglobulin receptor, and the gut microbiota promotes host-microbial mutualism. Immunol Lett 2014;162:10–21.

Mäkivuokko H, Lahtinen SJ, Wacklin P, dkk. Association between the ABO blood group and the human intestinal microbiota composition. BMC Microbiol 2012;12:94.

Janzon A, Goodrich JK, Koren O, Waters JL, Ley RE. Interactions between the Gut Microbiome and Mucosal Immunoglobulins A, M, and G in the Developing Infant Gut. mSystems 2019;4:1–17.

Altmann F, Kosma P, O’Callaghan A, dkk. Genome analysis and characterisation of the exopolysaccharide produced by bifidobacterium longum subsp. Longum 35624TM. PLoS One 2016;11:1–23.

Turroni F, Serafini F, Ventura M. Role of sortase-dependent pili of Bifidobacterium bifidum PRL2010 in modulating bacterium – host interactions. Proc Natl Acad Sci. 2013;110(27):11151–6.

Turroni F, Milani C, Duranti S, dkk. Deciphering bifidobacterial-mediated metabolic interactions and their impact on gut microbiota by a multi-omics approach. ISME J 2016;10:1656–68.

Wang G, Huang S, Wang Y, dkk. Bridging intestinal immunity and gut microbiota by metabolites. Cell Mol Life Sci 2019;76:3917–37.

Sandall J, Tribe RM, Avery L, dkk. Short-term and long-term effects of caesarean section on the health of women and children. Lancet 2018;392:1349–57.

Ahmadizar F, Vijverberg SJH, Arets HGM, dkk. Early-life antibiotic exposure increases the risk of developing allergic symptoms later in life: A meta-analysis. Allergy Eur J Allergy Clin Immunol 2018;73:971–86.

Akay HK, Bahar Tokman H, Hatipoglu N, dkk. The relationship between bifidobacteria and allergic asthma and/or allergic dermatitis: A prospective study of 0-3 years-old children in Turkey. Anaerobe 2014;28:98–103.

Fieten KB, Totté JEE, Levin E, dkk. Fecal microbiome and food allergy in pediatric atopic dermatitis: A cross-sectional pilot study. Int Arch Allergy Immunol 2018;17:77–84.

Wang HT, Anvari S, Anagnostou K. The Role of Probiotics in Preventing Allergic Disease. Children (Basel) 2019;6:24.

Fu L, Song J, Wang C, Fu S, Wang Y. Bifidobacterium infantis potentially alleviates shrimp tropomyosin-induced allergy by tolerogenic dendritic cell-dependent induction of regulatory T cells and alterations in gut microbiota. Front Immunol 2017;8:1–14.

Liu Q, Jing W, Wang W. Bifidobacterium lactis Ameliorates the Risk of Food Allergy in Chinese Children by Affecting Relative Percentage of Treg and Th17 Cells. Can J Infect Dis Med Microbiol 2018:2018: 4561038.

Taniuchi S, Hattori H, Yamammoto, dkk. Administration of Bifidobacterium to Infants with Atopic Dermatitis: Changes in Fecal Microflora and Clinical Symptoms. J Appl Res 2005;5:386-396.

Enomoto T, Sowa M, Nishimori K, dkk. Effects of bifidobacterial supplementation to pregnant women and infants in the prevention of allergy development in infants and on fecal microbiota. Allergol Int 2014;63:575–85.

Miraglia Del Giudice M, Indolfi C, Ciprandi G. Bifidobacterium mixture (B longum BB536, B infantis M-63, B breve M-16V) treatment in children with Seasonal Allergic Rhinitis and Intermittent Asthma. Ital J Pediatr 2017;43:25.

Zuccotti G, Meneghin F, Aceti A, dkk. Probiotics for prevention of atopic diseases in infants: Systematic review and meta-analysis. Allergy Eur J Allergy Clin Immunol 2015;70:1356–71.

Navarro-Lopez V, Ramirez-Bosca A, Ramon-Vidal D, dkk. Effect of oral administration of a mixture of probiotic strains on SCORAD index and use of topical steroids in young patients with moderate atopic dermatitis a randomized clinical trial. JAMA Dermatol 2018;154:37–43.

Xiao L, Gong C, Ding Y, dkk. Probiotics maintain intestinal secretory immunoglobulin A levels in healthy formula-fed infants: A randomised, double-blind, placebo-controlled study. Benef Microbes 2019;10:729–39.

Kim SO, Ah YM, Yu YM, Choi KH, Shin WG, Lee JY. Effects of probiotics for the treatment of atopic dermatitis: A meta-analysis of randomized controlled trials. Ann Allergy, Asthma Immunol 2014;113:217–26.

Gerasimov SV, Vasjuta VV, Myhovych OO, Bondarchuk LI. Probiotic supplement reduces Atopic Dermatitis in preschool children: A randomized, double-blind, placebo-controlled, clinical trial. Am J Clin Dermatol 2010;11:351–61.

Van Der Aa LB, Heymans HS, Van Aalderen WM, dkk. Effect of a new synbiotic mixture on atopic dermatitis in infants: A randomized-controlled trial. Clin Exp Allergy 2010;40:795–804.

Underwood MA, Kalanetra KM, Bokulich NA, dkk. A comparison of two probiotic strains of bifidobacteria in premature infants. J Pediatr 2013;163:1585-1591.e9.

Wong CB, Iwabuchi N, Xiao JZ. Exploring the science behind Bifidobacterium breve M-16V in infant health. Nutrients 2019;11:8.

Meyer MP, Chow SSW, Alsweiler J, dkk. Probiotics for Prevention of Severe Necrotizing Enterocolitis: Experience of New Zealand Neonatal Intensive Care Units. Front Pediatr 2020;8:119.

Lau ASY, Yanagisawa N, Hor YY, dkk. Bifidobacterium longum BB536 alleviated upper respiratory illnesses and modulated gut microbiota profiles in Malaysian pre-school children. Benef Microbes 2018;9:61–70.




DOI: http://dx.doi.org/10.14238/sp22.6.2021.394-400

Refbacks

  • Saat ini tidak ada refbacks.


##submission.copyrightStatement##

##submission.license.cc.by-nc-sa4.footer##

Informasi Editorial:
Badan Penerbit Ikatan Dokter Anak Indonesia
Jl. Salemba I No 5, Jakarta 10430, Indonesia
Phone/Fax: +62-21-3912577
Email: editorial [at] saripediatri.org

Lisensi Creative Commons
Sari Pediatri diterbitkan oleh Badan Penerbit Ikatan Dokter Anak Indonesia
Ciptaan disebarluaskan di bawah Lisensi Creative Commons Atribusi-NonKomersial-BerbagiSerupa 4.0 Internasional.